Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070

Watchlist Manager
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC Logo
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
Watchlist
Price: 27.9 SAR 2.57% Market Closed
Market Cap: 3.3B SAR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC stock under the Base Case scenario is 50.95 SAR. Compared to the current market price of 27.9 SAR, Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC is Undervalued by 45%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
50.95 SAR
Undervaluation 45%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2
P/S
P/S
Price to Sales
2
vs History
68
vs Industry
50
Median 3Y
2.2
Median 5Y
2.4
Industry
2.4
Forward
1.8
More Details
135.7
P/E
P/E
Price to Earnings
135.7
vs History
9
vs Industry
0
Median 3Y
-32.4
Median 5Y
-10.6
Industry
20.3
Forward
25
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
20
Median 3Y
-10.1
Median 5Y
7.2
Industry
15.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
24
Median 3Y
-11.6
Median 5Y
-21.3
Industry
23.1
More Details
2.4
P/B
P/B
Price to Book Value
2.4
vs History
38
vs Industry
33
Median 3Y
2.4
Median 5Y
2.4
Industry
2
More Details
2.7
EV/S
EV/S
Enterprise Value to Sales
2.7
vs History
61
vs Industry
40
Median 3Y
2.8
Median 5Y
2.9
Industry
2.5
Forward
2.4
More Details
5.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.4
vs History
76
vs Industry
35
Median 3Y
6.5
Median 5Y
6.5
Industry
4.8
More Details
20.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.1
vs History
61
vs Industry
15
Median 3Y
26.2
Median 5Y
25
Industry
12.5
Forward
15.5
More Details
32.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
32.3
vs History
47
vs Industry
10
Median 3Y
32.3
Median 5Y
32.3
Industry
15.7
Forward
25.3
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
17
Median 3Y
-13.7
Median 5Y
9.1
Industry
14.1
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
5
Median 3Y
-18.4
Median 5Y
-19
Industry
17.6
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
52
vs Industry
49
Median 3Y
1.3
Median 5Y
1.4
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
SA
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
3.3B SAR 2 135.7 20.1 32.3
US
Eli Lilly and Co
NYSE:LLY
735.1B USD 15 66.2 35.6 38.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
374.8B USD 4.2 17.3 12.6 16.5
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK 6.9 19.8 13 14.8
CH
Roche Holding AG
SIX:ROG
211.4B CHF 3.5 25.5 9.6 11.2
UK
AstraZeneca PLC
LSE:AZN
162.6B GBP 3.9 27.9 130.7 197
CH
Novartis AG
SIX:NOVN
180B CHF 4.1 17 10 13.4
US
Merck & Co Inc
NYSE:MRK
200.9B USD 3.1 11.5 8.3 9.9
IE
Endo International PLC
LSE:0Y5F
163.5B USD 70.5 -56 261.3 655.3
FR
Sanofi SA
PAR:SAN
114.9B EUR 1.3 9 5 5.9

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 253,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.